DNA BRANDS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In USD, except per-share amounts

	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Loss on disposal of fixed assets
(Gain) loss on embedded conversion option liabilities
Gain on conversion options, derivative liabilities
Non-cash interest expense related to discount on convertible debentures
Provision for doubtful accounts
Common stock issued in exchange for services
Common stock warrants, classified as derivative liabilities, issued in exchange for services
Allowance for doubtful accounts-includes allowance on employee receivables
Common stock and common stock warrants issued in exchange for services
Common stock issued in connection with convertible debt
Common stock issued as employee compensation
Share based compensation expense related to employee stock option grants
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other assets
Bank overdraft
Accounts payable
Accrued liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Proceeds from the sale of property and equipment
Loan receivable from related party
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Net proceeds from (payments on) bank overdraft
Net proceeds from officer loans
Net repayment of loans payable to related party
Net proceeds from loans payable
Net proceeds from (payments on) officer loans
Net proceeds from convertible debentures
Net proceeds from loans payable to related party
Repayments of loans payable
Net proceeds from the issuance of convertible preferred stock
Net proceeds from the issuance of common stock
Net proceeds from the exercise of common stock warrants
Net cash provided by financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures:
Interest paid
Income taxes paid
Supplemental disclosures of non-cash investing and financing activities:
Common stock issued in connection with conversion of loans payable to officers
Common stock issued in connection with conversion of convertible, subordinated debentures and accrued interest
Discount on convertible debentures
Preferred stock issued in connection with conversion of loans payable to officers
Common stock issued in connection with conversion of convertible debentures
Common stock issued in connection with conversion of accrued interest
Forgiveness of officers loans and accrued salaries contributed as capital
Discounts on convertible debentures
Warrants issued in conjunction with convertible debentures

Comments